Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ARWR
PCVX
Add up to 3 more stocks
ARWR
Arrowhead Pharmaceuticals, Inc.
+0.02%
$62.37+0.02Delayed quote: Oct 6, 2026, 3:00 PM EDT
Market Cap
$8.78B
52W Range
$34.61 - $95.49
PCVX
Vaxcyte, Inc.
-11.18%
$65.57-8.25Delayed quote: Oct 6, 2026, 3:00 PM EDT
Market Cap
$9.47B
52W Range
$39.87 - $90.75
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 18.87 | 3.43 |
| P/S Ratio | 13.12 | N/A |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 100.0% | 0.0% |
| Operating Margin | 11.9% | 0.0% |
| Net Margin | -47.8% | 0.0% |
| ROE | -68.7% | -38.6% |
| ROA | -15.2% | -33.9% |
| ROIC | -12.1% | -40.6% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 5.90 | 5.72 |
| Quick Ratio | 5.90 | 5.72 |
| Debt/Equity | 1.86 | 0.04 |
| Interest Coverage | 1.10 | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.